BIM
GILD icon

BRC Investment Management’s Gilead Sciences GILD Stock Holding History

BRC Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-189,237
Closed -$17.4M – 126
2016
Q1 		$17.4M Buy
189,237
+18,044
+11% +$1.63M 2.58% 20
2015
Q4 		$17.3M Buy
171,193
+2,183
+1% +$227K 2.54% 23
2015
Q3 		$16.6M Sell
169,010
-4,502
-3% -$500K 2.56% 17
2015
Q2 		$20.3M Buy
+173,512
New +$19M 2.8% 10
2014
Q3 		– Sell
-3,195
Closed -$265K – 137
2014
Q2 		$265K Hold
3,195
– – 0.04% 128
2014
Q1 		$226K Buy
+3,195
New +$251K 0.04% 134

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BRC Investment Management's GILD Position: Q2 2016 in Review

BRC Investment Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 189,237 shares — an estimated $17.4M sold.

BRC Investment Management first reported a position in GILD in Q1 2014 and held it in 6 quarters. The position peaked at $20.3M in Q2 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • BRC Investment Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • BRC Investment Management sold 189,237 Gilead Sciences shares in Q2 2016, an estimated $17.4M.
  • BRC Investment Management first reported a position in Gilead Sciences in Q1 2014 and held it in 6 quarters.
  • BRC Investment Management's Gilead Sciences position peaked at $20.3M in Q2 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on BRC Investment Management's 13F filing for Q2 2016, filed 5 Aug 2016.